1. The leading life sciences clusters in Europe
September 2015
With the support of
© Science|Business 2015

2. The RESEARCH : A MAPPING project
An editorial special report
Cluster definition
Innovation criteria:
Quantitative indicators (Data gathered from Eurostat, the World Bank, OECD, national and regional sources)
Qualitative research criteria (e.g. academic excellence, ease to do business)
Stakeholder interviews
© Science|Business 2015
9/21/2018

3. Map of the clusters
© Science|Business 2015
9/21/2018

4. INNOVATION success factors
Long history of medical research
Highly educated workforce
State of the art research infrastructures
Well-established technology transfer organisations
Good interchange/networking between companies, research centres, academic institutes and government agencies
© Science|Business 2015
9/21/2018

5. INNOVATION-driven measures
Sustained (financial) government support
Tax credit/exemptions for companies engaged in in-house R&D
Fast approval for clinical trials
Diversification of areas of excellence
© Science|Business 2015
9/21/2018

6. Investments for the future
Hagastaden: an innovative city in Sweden
One of Stockholm’s largest urban development projects
Designed to host a new university hospital; the expansion of the Karolinska Institute Science Park and a new cancer therapy clinic
Total investment €6.5 billion including €1 billion from Stockholm city
Paris-Saclay: from excellence to innovation
Designed to host 22 higher education institutions and research institutes
€5 billion investment over 10 years of which €1.3 billion is dedicated to research and innovation programmes and €2.5 billion to scientific and academic buildings
Investments for the future
© Science|Business 2015
9/21/2018

7. Investments for the future
Francis Crick Institute: The biggest centre for translational biomedical research in Europe
A consortium of six of the UK's most successful scientific and academic organisations
£650 million investment
1,500 staff, including 1,250 scientists
Ireland: a mini-Juncker plan?
In 2013, SFI invested €200 million in 7 research centres
Leveraging €100 million from industry
© Science|Business 2015
9/21/2018

8. Challenges are country-specific
Basic research is underfinanced (Vienna)
Lack of tax incentives for companies investing in R&D (Switzerland)
Some leading pharma companies are downsizing, and invest less in R&D (e.g. Medicon Valley)
Governance and organisational simplification is needed (Paris)
Lack of venture capital and difficulties in attracting new sources of capital (Berlin, Munich)
Technology transfer is too fragmented across competing institutions and departments (Heidelberg)
Shortage of top researchers (Ireland)
Lack of skilled management professionals in the life sciences industry (Oslo)
Low level of patenting (Stockholm-Uppsala)
© Science|Business 2015
9/21/2018

9. Study available Science|Business website at:
Contact:
Maryline fiaschi
TEL:
© Science|Business 2015